News for Dynavax Technologies Corporation - Google Finance

Keryx Biopharmaceuticals (KERX), Dynavax Technologies Corporation (DVAX ...

Wed, 22 May 2013 18:37:55 GMT

Keryx Biopharmaceuticals (KERX), Dynavax Technologies Corporation (DVAX ...
Insider Monkey (blog) - May 22, 2013

Dynavax Technologies Corporation (NASDAQ:DVAX) is a good case in point. The company's Heplisav hepatitis B vaccine looked good in clinical trials when compared to the leading vaccine on the market.

Dynavax Technologies Corp (DVAX) Reports In-Line Q1 EPS

Mon, 06 May 2013 20:04:03 GMT

Dynavax Technologies Corp (DVAX) Reports In-Line Q1 EPS
StreetInsider.com (subscription) - May 6, 2013

Dynavax Technologies Corp (NASDAQ: DVAX) reported Q1 EPS of ($0.11), in-line with the analyst estimate of ($0.11). For the quarter ended March 31, 2013, Dynavax reported total revenues of $2.1 million compared to $2.4 million for the quarter ended ...

DYNAVAX TECHNOLOGIES CORPORATION : Dynavax Reports First Quarter ... - 4-traders (press release)
Investors Alert: Dynavax Technologies Corporation, PDC Energy Inc, Boyd ... - SBWire (press release)

NASDAQ Decliners Watch List: Dynavax Technologies Corporation (NASDAQ ...

Sun, 28 Apr 2013 15:26:27 GMT

NASDAQ Decliners Watch List: Dynavax Technologies Corporation (NASDAQ ...
SBWire (press release) - Apr 28, 2013

New York, NY -- (SBWIRE) -- 04/28/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Dynavax Technologies Corporation (NASDAQ:DVAX), Nanosphere, Inc. (NASDAQ:NSPH), and Delcath Systems, Inc.

Dynavax Technologies Corporation (NASDAQ:DVAX), Nanosphere, Inc ...

Fri, 26 Apr 2013 17:40:01 GMT

Dynavax Technologies Corporation (NASDAQ:DVAX), Nanosphere, Inc ...
SBWire (press release) - Apr 26, 2013

Dynavax Technologies Corporation (NASDAQ:DVAX) a clinical-stage biopharmaceutical company that discovers and develops novel products to prevent and treat infectious and inflammatory diseases is currently down (-3.20%) on 897,308 shares traded.

Stocks Closing In The Green: Dynavax Technologies Corporation (NASDAQ ...

Sat, 04 May 2013 12:05:35 GMT

Stocks Closing In The Green: Dynavax Technologies Corporation (NASDAQ ...
NIS - May 4, 2013

New York, NY - (NISMAGAZINE) - 04/05/2013- Dynavax Technologies Corporation (NASDAQ:DVAX) rose 5.48% at $2.31 after trading 1.34 million shares.

Dynavax Technologies Corporation (NASDAQ:DVAX) down by 4%, Tellabs Inc ...

Fri, 26 Apr 2013 17:48:26 GMT

Dynavax Technologies Corporation (NASDAQ:DVAX) down by 4%, Tellabs Inc ...
NIS - Apr 26, 2013

New York, NY - (NISMAGAZINE) - 04/26/2013- Dynavax Technologies Corporation (NASDAQ:DVAX) plunged by 4.00% after opening at $2.92, throughout the stock traded in a band of $2.42 and $2.48.

Dynavax Technologies Corporation (NASDAQ:DVAX) up by 5.48%, Vonage ...

Sun, 05 May 2013 17:15:29 GMT

Dynavax Technologies Corporation (NASDAQ:DVAX) up by 5.48%, Vonage ...
NIS - May 5, 2013

New York, NY - (NISMAGAZINE) - 05/05/2013- Dynavax Technologies Corporation (NASDAQ:DVAX) shows bullish trend since it made an upward movement of 5.48% with trading volume of 1.34 million shares, in contrast to the 30 days average daily trading ...

Cincinnati Bell Inc. (NYSE:CBB) down by 3.07%, Rentech Inc. (NYSEMKT:RTK ...

Sun, 28 Apr 2013 16:15:20 GMT

Cincinnati Bell Inc. (NYSE:CBB) down by 3.07%, Rentech Inc. (NYSEMKT:RTK ...
NIS - Apr 28, 2013

New York, NY - (NISMAGAZINE) - 04/28/2013- Cincinnati Bell Inc. (NYSE:CBB) plunged 3.07% and closed to $3.47. The stock recorded the volume of 1.56 million shares.

Wider-than-Expected Loss at Dynavax - Analyst Blog

Tue, 07 May 2013 15:37:50 GMT

Wider-than-Expected Loss at Dynavax - Analyst Blog
NASDAQ - May 7, 2013

Dynavax Technologies Corporation ( DVAX ) suffered a loss of 11 cents per share in the first quarter of 2013, wider than the Zacks Consensus Estimate of a loss of 10 cents per share but flat year over year.

Dynavax Names Eddie Gray CEO; Meeting Scheduled With FDA For HEPLISAV

Tue, 30 Apr 2013 13:54:21 GMT

Dynavax Names Eddie Gray CEO; Meeting Scheduled With FDA For HEPLISAV
NASDAQ - Apr 30, 2013

(RTTNews.com) - biopharmaceutical company Dynavax Technologies Corporation ( DVAX ) said it appointed Eddie Gray as chief executive officer and a member of its board, effective May 1, 2013.